BriaCell Therapeutics (STU:8BT) Float Percentage Of Total Shares Outstanding: 99.95% (As of Jul. 13, 2026)


STU:8BT BriaCell Therapeutics Corp STU:8BT
22 GF Score
Price €5.56
! 2 Warning Signs
View Full Analysis

What is BriaCell Therapeutics Float Percentage Of Total Shares Outstanding?

BriaCell Therapeutics STU:8BT 22 Float Percentage Of Total Shares Outstanding is 99.95% as of Jul. 13, 2026. GuruFocus rates STU:8BT with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BriaCell Therapeutics's float shares is 8.70 Mil. BriaCell Therapeutics's total shares outstanding is 8.70 Mil. BriaCell Therapeutics's float percentage of total shares outstanding is 99.95%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BriaCell Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BriaCell Therapeutics's Institutional Ownership is 0.04%.

STU:8BT
22GF Score
BriaCell Therapeutics Corp STU:8BT
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BriaCell Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BriaCell Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.70/8.70
=99.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.95% mean?
BriaCell Therapeutics (STU:8BT) has a Float Percentage Of Total Shares Outstanding of 99.95% as of Jul. 13, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BriaCell Therapeutics and its competitors.
Is BriaCell Therapeutics' Float Percentage Of Total Shares Outstanding too high?
BriaCell Therapeutics' current Float Percentage Of Total Shares Outstanding is 99.95%. Overall, BriaCell Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does BriaCell Therapeutics' Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
BriaCell Therapeutics' Float Percentage Of Total Shares Outstanding of 99.95% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BriaCell Therapeutics and its competitors. BriaCell Therapeutics's current Float Percentage Of Total Shares Outstanding is 99.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BriaCell Therapeutics stock overvalued right now?
BriaCell Therapeutics (STU:8BT) has a current Float Percentage Of Total Shares Outstanding of 99.95%. The current Float Percentage Of Total Shares Outstanding is 99.95%. BriaCell Therapeutics' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For BriaCell Therapeutics (STU:8BT), the current Float Percentage Of Total Shares Outstanding is 99.95% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BriaCell Therapeutics Business Description

Address 235-15th Street, Suite 300, 3rd Floor, Bellevue Centre, West Vancouver, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
22GF Score

Get the complete analysis for STU:8BT

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.56
Price